<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00881335</url>
  </required_header>
  <id_info>
    <org_study_id>SHDC12007211-O</org_study_id>
    <nct_id>NCT00881335</nct_id>
  </id_info>
  <brief_title>Implemental Flutter Mucus Clearance Devices on Geriatric Lung Function</brief_title>
  <official_title>Implemental Flutter Mucus Clearance Devices on Geriatric Lung Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tongji University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tongji University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the clinical outcome and safety of flutter mucus
      clearance devices in elders of gerocomium.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Respiratory diseases are still increasing in the elderly population. The fluttering mucus
      clearance technique is expected to be a physical assisting therapy enhancing airway secretion
      clearance but needs more clinical randomized, controlled trial evidence.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">May 2009</completion_date>
  <primary_completion_date type="Actual">May 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Cases With Fever (Body Temperature Reach 38 Degree Celsius or Higher)</measure>
    <time_frame>up to 28 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>MPEF,Mean Peak Expiratory Flow</measure>
    <time_frame>up to 28 days</time_frame>
    <description>indicators of pulmonary function, for example, PEF(unit of measurement:Liter per minute) All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>FEV1, Forced Expiratory Volume at First Second</measure>
    <time_frame>up to 28 days</time_frame>
    <description>indicators of pulmonary function, for example, FEV1(unit of measurement:Liter)
All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>FVC, Forced Vital Capacity</measure>
    <time_frame>up to 28 days</time_frame>
    <description>indicators of pulmonary function, for example, FVC(unit of measurement:Liter)
All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>FEV1/FVC%, the Ratio of FEV1 to FVC</measure>
    <time_frame>up to 28 days</time_frame>
    <description>indicators of pulmonary function,
All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Cases With Antibiotics Therapy</measure>
    <time_frame>up to 28 days</time_frame>
    <description>antibiotics therapy is the indicators of pulmonary infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Cases With Hospital Visit</measure>
    <time_frame>up to 28 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention group were given flutter valve mucus clearance devices to do pulmonary function exercise</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>flutter mucus clearance device</intervention_name>
    <description>five minutes every sessions, three sessions per day</description>
    <arm_group_label>intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  available to perform the device, the elders in geracomium

          -  male and female

          -  aging 85 years or more

        Exclusion Criteria:

          -  not available to perform the procedure

          -  untreated pneumothorax

          -  diffusion interstitial lung disease

          -  acute coronary syndrome

          -  third stage hypertension

          -  advanced cancer

          -  severe heart, liver, renal, blood system and endocrine system dysfunction

          -  noninvasive mechanical ventilation

          -  active hemoptysis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>85 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhang Xiangyu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai Tebth People's Hospital</affiliation>
  </overall_official>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2009</study_first_submitted>
  <study_first_submitted_qc>April 14, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2009</study_first_posted>
  <results_first_submitted>June 17, 2009</results_first_submitted>
  <results_first_submitted_qc>May 17, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 20, 2012</results_first_posted>
  <last_update_submitted>June 25, 2012</last_update_submitted>
  <last_update_submitted_qc>June 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 29, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tongji University</investigator_affiliation>
    <investigator_full_name>Zhang Xiangyu</investigator_full_name>
    <investigator_title>MD, director, professor, FCCM, FCCP.</investigator_title>
  </responsible_party>
  <keyword>geriatric</keyword>
  <keyword>pulmonary disease</keyword>
  <keyword>flutter</keyword>
  <keyword>sputum</keyword>
  <keyword>physical therapy techniques</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>recuitment period: April 19th, May 17th location: Redsun geracomium</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Intervention Group</title>
          <description>all the subjects received portable mucus clearance devices to do pulmonary function rehabilitation.</description>
        </group>
        <group group_id="P2">
          <title>Control Group</title>
          <description>without any intervention</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27">3 participants did not complete the period</participants>
                <participants group_id="P2" count="28">2 participants did not complete the period</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Intervention Group</title>
          <description>all the subjects received portable mucus clearance devices to do pulmonary function rehabilitation.</description>
        </group>
        <group group_id="B2">
          <title>Control Group</title>
          <description>without any intervention</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
            <count group_id="B2" value="30"/>
            <count group_id="B3" value="60"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="86.81" spread="2.06"/>
                    <measurement group_id="B2" value="87.57" spread="2.95"/>
                    <measurement group_id="B3" value="87.20" spread="2.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>China</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Cases With Fever (Body Temperature Reach 38 Degree Celsius or Higher)</title>
        <time_frame>up to 28 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention Group</title>
            <description>all the subjects received portable mucus clearance devices to do pulmonary function rehabilitation.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>without any intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Cases With Fever (Body Temperature Reach 38 Degree Celsius or Higher)</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Cases With Antibiotics Therapy</title>
        <description>antibiotics therapy is the indicators of pulmonary infection</description>
        <time_frame>up to 28 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention Group</title>
            <description>all the subjects received portable mucus clearance devices to do pulmonary function rehabilitation.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>without any intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Cases With Antibiotics Therapy</title>
          <description>antibiotics therapy is the indicators of pulmonary infection</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>MPEF,Mean Peak Expiratory Flow</title>
        <description>indicators of pulmonary function, for example, PEF(unit of measurement:Liter per minute) All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study.</description>
        <time_frame>up to 28 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention Group</title>
            <description>all the subjects received portable mucus clearance devices to do pulmonary function rehabilitation.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>without any intervention</description>
          </group>
        </group_list>
        <measure>
          <title>MPEF,Mean Peak Expiratory Flow</title>
          <description>indicators of pulmonary function, for example, PEF(unit of measurement:Liter per minute) All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study.</description>
          <units>L/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="117.59" spread="50.39"/>
                    <measurement group_id="O2" value="103.93" spread="41.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>FEV1, Forced Expiratory Volume at First Second</title>
        <description>indicators of pulmonary function, for example, FEV1(unit of measurement:Liter)
All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study.</description>
        <time_frame>up to 28 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention Group</title>
            <description>all the subjects received portable mucus clearance devices to do pulmonary function rehabilitation.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>without any intervention</description>
          </group>
        </group_list>
        <measure>
          <title>FEV1, Forced Expiratory Volume at First Second</title>
          <description>indicators of pulmonary function, for example, FEV1(unit of measurement:Liter)
All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study.</description>
          <units>L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.01" spread="0.37"/>
                    <measurement group_id="O2" value="1.02" spread="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>FVC, Forced Vital Capacity</title>
        <description>indicators of pulmonary function, for example, FVC(unit of measurement:Liter)
All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study.</description>
        <time_frame>up to 28 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention Group</title>
            <description>all the subjects received portable mucus clearance devices to do pulmonary function rehabilitation.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>without any intervention</description>
          </group>
        </group_list>
        <measure>
          <title>FVC, Forced Vital Capacity</title>
          <description>indicators of pulmonary function, for example, FVC(unit of measurement:Liter)
All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study.</description>
          <units>L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.06" spread="0.73"/>
                    <measurement group_id="O2" value="1.77" spread="0.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>FEV1/FVC%, the Ratio of FEV1 to FVC</title>
        <description>indicators of pulmonary function,
All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study.</description>
        <time_frame>up to 28 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention Group</title>
            <description>all the subjects received portable mucus clearance devices to do pulmonary function rehabilitation.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>without any intervention</description>
          </group>
        </group_list>
        <measure>
          <title>FEV1/FVC%, the Ratio of FEV1 to FVC</title>
          <description>indicators of pulmonary function,
All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study.</description>
          <units>ratios</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.67" spread="16.83"/>
                    <measurement group_id="O2" value="59.04" spread="13.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Cases With Hospital Visit</title>
        <time_frame>up to 28 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention Group</title>
            <description>all the subjects received portable mucus clearance devices to do pulmonary function rehabilitation.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>without any intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Cases With Hospital Visit</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Intervention Group</title>
          <description>all the subjects received portable mucus clearance devices to do pulmonary function rehabilitation.</description>
        </group>
        <group group_id="E2">
          <title>Control Group</title>
          <description>without any intervention</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Zhang Xiangyu</name_or_title>
      <organization>Shanghai Tenth People's Hospital, Tongji University</organization>
      <phone>86-21-66307174</phone>
      <email>xiangyu62@126.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

